-
Symbol
-
IRD on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Ownership
-
9.49M shares
-
Security Ownership
-
15.9%
Foundation Fighting Blindness Retinal Degeneration Fund ownership in Opus Genetics, Inc. Common Stock, $0.0001 par value per share (IRD)
2025-05-06 - Foundation Fighting Blindness Retinal Degeneration Fund has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9.49M shares of Opus Genetics, Inc. Common Stock, $0.0001 par value per share (IRD).
This represents 15.9% percent ownership of the company.